Breaking News, Promotions & Moves

High Purity New England Appoints Chief Scientific Officer

Dr. Michael Quesenberry will serve as a subject-matter expert for bioprocess development.

Author Image

By: Charlie Sternberg

Associate Editor

High Purity New England, a supplier of equipment, process systems, and custom solutions for the biopharma industry, has appointed a new chief scientific officer, Dr. Michael Quesenberry.   As a biopharma industry veteran, Quesenberry will bring his wealth of bioprocessing knowledge in both cGMP manufacturing and process development to the HPNE team, helping to advance the mission of the organization as it continues its high-growth trajectory.   With a Ph.D in Biochemistry and Molecular Biology f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters